Li S, Chen W, Srinivasan S R, Boerwinkle E, Berenson G S
Tulane Center for Cardiovascular Health, Tulane University Health Sciences Center, New Orleans, LA 70112, USA.
Int J Obes (Lond). 2006 Aug;30(8):1183-8. doi: 10.1038/sj.ijo.0803281. Epub 2006 Mar 14.
To investigate the influence of lipoprotein lipase (LPL) Ser447Stop and beta1-adrenergic receptor (ADRB1) Arg389Gly gene polymorphisms, individually and in combination, on obesity from childhood to adulthood.
A community-based cohort of 1331 subjects (30% black and 70% white subjects) was followed over an average period of 23 years from childhood (age range: 4-17 years) to adulthood (age range:18-44 years).
Body mass index (BMI, kg/m2) and LPL Ser447Stop and the ADRB1 Arg389Gly genotypes.
The frequency of the ADRB1 Gly389 allele was 0.25 in white subjects vs 0.39 in black subjects (P < 0.001); 0.08 vs 0.05 (P = 0.280) for the LPL Stop447 allele. There was no association between the LPL Stop447 allele and BMI among white and black subjects either in childhood and adulthood levels or annual change from childhood to adulthood. The ADRB1 Gly389 allele was associated with lower BMI only in black adults (P = 0.017). Further, the interaction effect of the LPL Stop447 allele and ADRB1 Gly389 allele on adult BMI or its annual change was significant in white subjects and in the total sample (P = 0.03-0.006). Childhood values tended to show a similar trend. Having both ADRB1 Gly389 allele and LPL Stop447 allele was associated with 71% (95% confidence interval: 26-89%) less odds for developing obesity from childhood to adulthood after adjusting for age, race, sex, and childhood BMI.
While Gly389 allele of the ADRB1 gene lowers obesity in black subjects, this allele in conjunction with Stop447 allele of the LPL gene lowers obesity in adults and attenuates the development of obesity from childhood to adulthood. These findings underscore the importance of gene-gene interaction in the assessment of genetic influences on complex traits such as obesity.
研究脂蛋白脂肪酶(LPL)Ser447Stop和β1 - 肾上腺素能受体(ADRB1)Arg389Gly基因多态性单独及联合作用对从儿童期到成年期肥胖的影响。
对一个基于社区的队列中的1331名受试者(30%为黑人,70%为白人)进行了平均23年的随访,随访时间从儿童期(年龄范围:4 - 17岁)至成年期(年龄范围:18 - 44岁)。
体重指数(BMI,kg/m²)以及LPL Ser447Stop和ADRB1 Arg389Gly基因分型。
ADRB1 Gly389等位基因在白人受试者中的频率为0.25,在黑人受试者中为0.39(P < 0.001);LPL Stop447等位基因频率在白人中为0.08,在黑人中为0.05(P = 0.280)。在儿童期和成年期水平以及从儿童期到成年期的年度变化方面,白人及黑人受试者中LPL Stop447等位基因与BMI均无关联。ADRB1 Gly389等位基因仅在成年黑人中与较低的BMI相关(P = 0.017)。此外,LPL Stop447等位基因与ADRB1 Gly389等位基因对成人BMI或其年度变化的交互作用在白人受试者及总样本中具有显著性(P = 0.03 - 0.006)。儿童期数值也呈现出类似趋势。在调整年龄、种族、性别和儿童期BMI后,同时拥有ADRB1 Gly389等位基因和LPL Stop447等位基因的个体从儿童期到成年期发生肥胖的几率降低了71%(95%置信区间:26 - 89%)。
虽然ADRB1基因的Gly389等位基因可降低黑人受试者的肥胖程度,但该等位基因与LPL基因的Stop447等位基因共同作用可降低成年人的肥胖程度,并减弱从儿童期到成年期肥胖的发展。这些发现强调了基因 - 基因相互作用在评估遗传因素对肥胖等复杂性状影响中的重要性。